|
COX18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.704200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.786100E-02 |
| Normal-vs-Stage2 |
3.200800E-03 |
| Normal-vs-Stage3 |
3.076200E-01 |
| Normal-vs-Stage4 |
5.228000E-01 |
| Stage1-vs-Stage2 |
3.121600E-02 |
| Stage1-vs-Stage3 |
5.913600E-01 |
| Stage1-vs-Stage4 |
3.935200E-01 |
| Stage2-vs-Stage3 |
1.948400E-02 |
| Stage2-vs-Stage4 |
1.539790E-02 |
| Stage3-vs-Stage4 |
7.574400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.826400E-01 |
| Normal-vs-AfricanAmerican |
2.026600E-01 |
| Normal-vs-Asian |
3.090200E-01 |
| Caucasian-vs-AfricanAmerican |
5.415200E-01 |
| Caucasian-vs-Asian |
8.386800E-01 |
| AfricanAmerican-vs-Asian |
6.879400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.421500E-02 |
| Normal-vs-Female |
1.468960E-01 |
| Male-vs-Female |
1.630360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.791970E-01 |
| Normal-vs-Age(41-60Yrs) |
2.942600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.984700E-03 |
| Normal-vs-Age(81-100Yrs) |
6.497600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.635200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.851860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.053400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.203680E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.607600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.927800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.847600E-01 |
| Classical-VS-Follicular |
7.205200E-04 |
| Classical-VS-Other |
6.440800E-01 |
| Classical-VS-Normal |
1.813200E-01 |
| Tall-VS-Follicular |
4.434200E-04 |
| Tall-VS-Other |
9.230200E-01 |
| Tall-VS-Normal |
9.913000E-01 |
| Follicular-VS-Other |
1.597180E-01 |
| Follicular-VS-Normal |
2.019500E-04 |
| Other-VS-Normal |
9.248000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.529660E-02 |
| Normal-vs-N1 |
5.890600E-01 |
| N0-vs-N1 |
2.703700E-03 |
|
|
